Century Therapeutics Inc (IPSC)
$2.09
$-0.02
(-0.95%)
As on 03-Sep-2026 16:00EDT
Market cap
$367 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.5 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
131.5
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1
-
Face value
--
-
Shares outstanding
181,075,321
9 Years Aggregate
CFO
$-116.66 Mln
EBITDA
$-393.58 Mln
Net Profit
$-664.07 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Century Therapeutics Inc (IPSC)
| 110.1 | 3.5 | -3.7 | 339.3 | -5.4 | -39.8 | -- |
|
BSE Sensex*
| -9.3 | -2.3 | 3.3 | -4.6 | 5.5 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Century Therapeutics Inc (IPSC)
| -1.5 | -69.3 | -35.3 | -67.7 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Century Therapeutics Inc (IPSC)
|
2.1 | 366.7 | 0.0 | -109.8 | -- | -56.1 | -- | 1.7 |
| 86.5 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 74.0 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 59.1 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 110.8 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 371.5 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 542.6 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 593.4 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 355.2 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 | |
| 148.8 | 9,339.4 | 282.0 | 82.9 | -28.6 | 11.4 | 140.1 | 11.5 |
Shareholding Pattern
View DetailsAbout Century Therapeutics Inc (IPSC)
Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-813, an... iPSC-derived beta islet cell replacement therapy engineered with Allo-Evasion 5.0 for the treatment of type 1 diabetes. The company is also involved in the development of CNTY-308, a CD19-targeted CD4+/CD8+ CAR-iT cell therapy engineered with Allo-Evasion 5.0 as a potential treatment for B-cell-mediated autoimmune diseases; and CNTY-101, an allogeneic, iPSC-derived CAR-iNK cell therapy with six precision gene edits engineered to express CD19 CAR, with Allo-Evasion 1.0 edits designed for the treatment of CD19 for B-cell mediated autoimmune diseases. Century Therapeutics, Inc. was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania. Read more
-
COO & Head of Early Development
Dr. Adrienne Farid Ph.D.
-
COO & Head of Early Development
Dr. Adrienne Farid Ph.D.
-
Headquarters
Philadelphia, PA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Century Therapeutics Inc (IPSC)
What is the current share price of Century Therapeutics Inc (IPSC) Today?
The share price of Century Therapeutics Inc (IPSC) is $2.09 (NASDAQ) as of 03-Sep-2026 16:00 EDT. Century Therapeutics Inc (IPSC) has given a return of -5.42% in the last 3 years.
What is the current PB & PE ratio of Century Therapeutics Inc (IPSC)?
Since, TTM earnings of Century Therapeutics Inc (IPSC) is negative, P/E ratio is not available.
The P/B ratio of Century Therapeutics Inc (IPSC) is 1.73 times as on 28-Aug-2026, a 67 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-8.99 |
0.54 |
2024 |
-0.63 |
0.49 |
2023 |
-1.45 |
1.08 |
2022 |
-2.29 |
0.99 |
2021 |
-9.02 |
2.18 |
What is the 52 Week High and Low of Century Therapeutics Inc (IPSC)?
The 52-week high and low of Century Therapeutics Inc (IPSC) are Rs 3.04 and Rs 0.44 as of 04-Sep-2026.
What is the market cap of Century Therapeutics Inc (IPSC)?
Century Therapeutics Inc (IPSC) has a market capitalisation of $ 367 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Century Therapeutics Inc (IPSC)?
Before investing in Century Therapeutics Inc (IPSC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.